Is Takeda Pharmaceutical Company Limited (TAK) a Buy, Sell, or Hold?
NYSE : TAK
Takeda Pharmaceutical Company Limited — Institutional Ownership
$17.44 USD
$0.2 (1.16%)
- Volume
- 3.68M
- Average Volume
- 3.25M
- Market Capitalization
- $55.48B
- P/E Ratio
- 47.09
- Dividend Yield
- 3.48%
- Price Target
- Year High
- $18.90
- Year Low
- $12.99
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.63
- Current Ratio
- $1.27
Institutional Ownership Summary
Institutional Ownership %
0.09%
Investors Holding
90
change: -276 | last: 366
Increased Positions
43
change: -186 | last: 229
Reduced Positions
22
change: -39 | last: 61
New Positions
18
change: -39 | last: 57
Sold Positions
289
change: 244 | last: 45
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -4.49 | last: 0.0449
Total Invested
47.7M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-12-09 | Takeda Pharmaceutical Company Limited | 8.78M | 12.30% |
| 2025-09-19 | Takeda Pharmaceutical Company Limited | - | 0.00% |
| 2025-09-19 | Takeda Vaccines Inc. | - | 0.00% |
| 2024-01-19 | Takeda Ventures, Inc. | 1.84M | 5.20% |
| 2024-01-19 | Takeda Pharmaceutical Company Limited | 1.84M | 5.20% |
| 2022-08-05 | Takeda Ventures, Inc. | 1.48M | 4.96% |
| 2022-08-05 | Takeda Pharmaceutical Company Limited | 1.48M | 4.96% |
| 2022-05-09 | Takeda Vaccines, Inc. | 6.72M | 17.10% |
| 2022-05-09 | Takeda Pharmaceutical Company Limited | 6.72M | 17.10% |
| 2022-04-21 | Millennium Pharmaceuticals, Inc. | 14.82M | 13.20% |
| 2022-04-21 | Takeda Pharmaceutical Company Limited | 14.82M | 13.20% |
| 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. | 90.91M | 5.70% |
| 2022-01-14 | Takeda Pharmaceutical Company Limited | 1.48M | 5.37% |
| 2022-01-14 | Takeda Pharmaceutical Company Limited | 6.01M | 7.00% |
| 2022-01-14 | Takeda Ventures, Inc. | 1.48M | 5.37% |
| 2021-11-12 | Takeda Pharmaceutical Company Limited | 7.46M | 19.20% |
| 2021-10-25 | Takeda Pharmaceuticals U.S.A., Inc. | 530.56K | 1.70% |
| 2021-10-25 | Takeda Pharmaceutical Company Limited | 530.56K | 1.70% |
| 2021-10-18 | Takeda Ventures, Inc. | 1.48M | 5.20% |
| 2021-10-18 | Takeda Pharmaceutical Company Limited | 1.48M | 5.20% |
| 2021-09-14 | Takeda Pharmaceuticals U.S.A., Inc. | 2.31M | 4.10% |
| 2021-09-14 | Takeda Pharmaceuticals International AG | 2.31M | 4.10% |
| 2021-09-14 | Takeda Pharmaceutical Company Limited | 2.31M | 4.10% |
| 2021-09-14 | Millennium Pharmaceuticals, Inc. | 2.31M | 4.10% |
| 2021-09-14 | Takeda A/S | - | 0.00% |
| 2021-09-14 | Takeda Europe Holdings B.V. | - | 0.00% |
| 2021-09-14 | Takeda Pharma A/S | - | 0.00% |
| 2021-04-01 | Takeda Pharmaceutical Company Limited | 8.67M | 22.30% |
| 2021-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | 94.03M | 6.00% |
| 2020-01-27 | Takeda Pharmaceutical Company Limited | 8.67M | 27.00% |
| 2020-01-24 | Millennium Pharmaceuticals, Inc. | 3.92M | 4.37% |
| 2020-01-24 | Takeda Pharmaceutical Company Limited | 3.92M | 4.37% |
| 2019-11-22 | Takeda Pharmaceutical Company Limited | 5.53M | 11.60% |
| 2019-11-22 | Millennium Pharmaceuticals, Inc. | 3.75M | 7.80% |
| 2019-11-06 | Takeda Pharmaceutical Company Limited | 8.67M | 24.70% |
| 2019-11-06 | Takeda Pharmaceutical Company Limited | 2.47M | 10.82% |
| 2019-11-06 | Takeda Ventures, Inc. | 2.47M | 10.82% |
| 2019-09-10 | Shire International GmbH | 1.86M | 8.10% |
| 2019-09-10 | Takeda Pharmaceutical Company Limited | 1.86M | 8.10% |
| 2019-05-20 | Takeda Pharmaceuticals International AG | 1.12M | 4.20% |
| 2019-05-20 | Takeda Ventures, Inc. | 2.68M | 9.90% |
| 2019-05-20 | Takeda Pharmaceuticals U.S.A., Inc. | 2.68M | 9.90% |
| 2019-05-20 | Takeda Pharmaceutical Company Limited | 2.68M | 9.90% |
| 2019-04-26 | 6.2%(1) | 1.33M | 6.20% |
| 2019-04-26 | 6.2%(2) | 1.33M | 6.20% |
| 2019-04-26 | 6.2%(2) | 1.33M | 6.20% |
| 2019-04-26 | in Row (9) | 558.91K | 2.60% |
| 2019-02-14 | CAUSEWAY CAPITAL MANAGEMENT LLC, TIN # 95-486180 | 43.15M | 5.43% |
| 2019-02-08 | GS Mezzanine Partners, L.P. | 1.07M | 2.14% |
| 2018-04-16 | Takeda Pharmaceutical Company Limited | 1.78M | 7.20% |
| 2013-03-28 | Takeda Pharmaceutical Company Limited | 7.4M | 8.00% |
| 2013-03-28 | Takeda Pharma A/S | 4.97M | 5.30% |
| 2013-03-28 | Takeda GmbH | 2.43M | 2.60% |
TAK Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2939.33 | 3.15B | $9.26T | $597.63B | $4.9T | $13.56T |
| 2025-03-31 | $2229.76 | 3.21B | $7.16T | $385.11B | $4.52T | $11.29T |
| 2024-03-31 | $2072.95 | 3.13B | $6.49T | $457.8B | $4.84T | $10.87T |
| 2023-03-31 | $2187.36 | 3.1B | $6.79T | $533.53B | $4.38T | $10.64T |
| 2022-03-31 | $1742.07 | 3.13B | $5.45T | $849.7B | $4.35T | $8.94T |
| 2021-03-31 | $2020.91 | 3.12B | $6.31T | $966.22B | $4.64T | $9.98T |
| 2020-03-31 | $1631.76 | 3.11B | $5.08T | $637.61B | $5.09T | $9.54T |
| 2019-03-31 | $2281.42 | 1.92B | $4.39T | $702.09B | $5.75T | $9.44T |
| 2018-03-31 | $2593.81 | 1.56B | $4.05T | $294.52B | $985.66B | $4.74T |
| 2017-03-31 | $2632.62 | 1.56B | $4.11T | $319.46B | $1.14T | $4.94T |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2939.33 | 3.12B | $9.19T | $597.63B | $4.9T | $13.49T |
| 2025-12-31 | $2445.32 | 3.16B | $7.73T | $655.38B | $4.86T | $11.93T |
| 2025-09-30 | $2163.84 | 3.15B | $6.83T | $681.49B | $4.65T | $10.79T |
| 2025-06-30 | $2225.85 | 3.13B | $6.97T | $350.01B | $4.51T | $11.12T |
| 2025-03-31 | $2229.76 | 3.16B | $7.05T | $385.11B | $4.52T | $11.18T |
| 2024-12-31 | $2082.81 | 3.17B | $6.6T | $494.13B | $4.84T | $10.95T |
| 2024-09-30 | $2042.32 | 3.17B | $6.47T | $859.02B | $5.05T | $10.66T |
| 2024-06-30 | $2093.56 | 3.14B | $6.57T | $804.27B | $5.48T | $11.25T |
| 2024-03-31 | $2072.95 | 3.14B | $6.5T | $457.8B | $4.84T | $10.89T |
| 2023-12-31 | $2011.39 | 3.14B | $6.31T | $288.36B | $4.66T | $10.69T |
| 2023-09-30 | $2310.01 | 3.13B | $7.23T | $318.05B | $4.68T | $11.59T |
| 2023-06-30 | $2266.64 | 3.11B | $7.05T | $316.38B | $4.75T | $11.48T |